Shuttle Pharmaceuticals Names Yuying Liang as Finance Chief

Dow Jones01-13

By Katherine Hamilton

Shuttle Pharmaceuticals named Yuying Liang as its next chief financial officer.

Liang will succeed Chris Cooper, who will continue to serve as interim chief executive, the cancer treatment company said Monday.

Liang, 35, has been working with the company via her company Yuying Liang Professional, where she has been performing bookkeeping, accounting and financial reporting.

Liang is a certified public accountant who has worked with public and private companies across multiple sectors. Most recently, she was named chief financial officer of iSpecimen in December 2024.

Liang also currently serves as chief financial officer of BlockchainK2, Goldhills Holding, Intact Gold, Kincora Copper, Transatlantic Mining and Ultra Brands. She is chief financial officer and director at Modern Plant Based Foods and Montego Resources.

Shuttle plans to pay Liang a monthly fee of $15,000 plus taxes, it said.

Separately, Sachin Pathigoda resigned from his position on the company's board of directors. The board has started looking for potential candidates to fill the vacancy.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

January 12, 2026 16:47 ET (21:47 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2603529692?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-13 05:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603529692","market":"fut","top_or_hot":-1,"title":"Shuttle Pharmaceuticals Names Yuying Liang as Finance Chief","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shuttle Pharmaceuticals named Yuying Liang as its next chief financial officer. \n</p>\n<p>\n  Liang will succeed Chris Cooper, who will continue to serve as interim chief executive, the cancer treatment company said Monday. \n</p>\n<p>\n  Liang, 35, has been working with the company via her company Yuying Liang Professional, where she has been performing bookkeeping, accounting and financial reporting. \n</p>\n<p>\n  Liang is a certified public accountant who has worked with public and private companies across multiple sectors. Most recently, she was named chief financial officer of iSpecimen in December 2024. \n</p>\n<p>\n  Liang also currently serves as chief financial officer of BlockchainK2, Goldhills Holding, Intact Gold, <a href=\"https://laohu8.com/S/BZDLF\">Kincora Copper</a>, Transatlantic Mining and <a href=\"https://laohu8.com/S/FLLLF\">Ultra Brands</a>. She is chief financial officer and director at <a href=\"https://laohu8.com/S/MDRNF\">Modern Plant Based Foods</a> and Montego Resources. \n</p>\n<p>\n  Shuttle plans to pay Liang a monthly fee of $15,000 plus taxes, it said. \n</p>\n<p>\n  Separately, Sachin Pathigoda resigned from his position on the company's board of directors. The board has started looking for potential candidates to fill the vacancy. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 12, 2026 16:47 ET (21:47 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shuttle Pharmaceuticals Names Yuying Liang as Finance Chief</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShuttle Pharmaceuticals Names Yuying Liang as Finance Chief\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-13 05:47</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shuttle Pharmaceuticals named Yuying Liang as its next chief financial officer. \n</p>\n<p>\n  Liang will succeed Chris Cooper, who will continue to serve as interim chief executive, the cancer treatment company said Monday. \n</p>\n<p>\n  Liang, 35, has been working with the company via her company Yuying Liang Professional, where she has been performing bookkeeping, accounting and financial reporting. \n</p>\n<p>\n  Liang is a certified public accountant who has worked with public and private companies across multiple sectors. Most recently, she was named chief financial officer of iSpecimen in December 2024. \n</p>\n<p>\n  Liang also currently serves as chief financial officer of BlockchainK2, Goldhills Holding, Intact Gold, <a href=\"https://laohu8.com/S/BZDLF\">Kincora Copper</a>, Transatlantic Mining and <a href=\"https://laohu8.com/S/FLLLF\">Ultra Brands</a>. She is chief financial officer and director at <a href=\"https://laohu8.com/S/MDRNF\">Modern Plant Based Foods</a> and Montego Resources. \n</p>\n<p>\n  Shuttle plans to pay Liang a monthly fee of $15,000 plus taxes, it said. \n</p>\n<p>\n  Separately, Sachin Pathigoda resigned from his position on the company's board of directors. The board has started looking for potential candidates to fill the vacancy. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 12, 2026 16:47 ET (21:47 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SHPH","symbol_name":"Shuttle Pharmaceuticals Inc","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2603529692","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603529692","pubTimestamp":1768254420,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shuttle Pharmaceuticals named Yuying Liang as its next chief financial officer.Liang will succeed Chris Cooper, who will continue to serve as interim chief executive, the cancer treatment company said Monday.Liang, 35, has been working with the company via her company Yuying Liang Professional, where she has been performing bookkeeping, accounting and financial reporting.Liang is a certified public accountant who has worked with public and private companies across multiple sectors. Most recently, she was named chief financial officer of iSpecimen in December 2024.Liang also currently serves as chief financial officer of BlockchainK2, Goldhills Holding, Intact Gold, Kincora Copper, Transatlantic Mining and Ultra Brands. She is chief financial officer and director at Modern Plant Based Foods and Montego Resources.Shuttle plans to pay Liang a monthly fee of $15,000 plus taxes, it said.Separately, Sachin Pathigoda resigned from his position on the company's board of directors. The board ha","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SHPH":"Shuttle Pharmaceuticals Inc","BK4139":"生物科技"},"translate_title":"Shuttle Pharmaceuticals任命梁玉英为财务总监","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SHPH":0.9},"content_text":"By Katherine Hamilton \n\n\n \n\n\n  Shuttle Pharmaceuticals named Yuying Liang as its next chief financial officer. \n\n\n  Liang will succeed Chris Cooper, who will continue to serve as interim chief executive, the cancer treatment company said Monday. \n\n\n  Liang, 35, has been working with the company via her company Yuying Liang Professional, where she has been performing bookkeeping, accounting and financial reporting. \n\n\n  Liang is a certified public accountant who has worked with public and private companies across multiple sectors. Most recently, she was named chief financial officer of iSpecimen in December 2024. \n\n\n  Liang also currently serves as chief financial officer of BlockchainK2, Goldhills Holding, Intact Gold, Kincora Copper, Transatlantic Mining and Ultra Brands. She is chief financial officer and director at Modern Plant Based Foods and Montego Resources. \n\n\n  Shuttle plans to pay Liang a monthly fee of $15,000 plus taxes, it said. \n\n\n  Separately, Sachin Pathigoda resigned from his position on the company's board of directors. The board has started looking for potential candidates to fill the vacancy. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 12, 2026 16:47 ET (21:47 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603529692","isCrawlerRequest":true}